Gastric cancer
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: 1) Patients undergoing laparoscopic radical gastrectomy that was expected to be more than 3h 2) Patients more than 65 years old and with American Society of Anaesthesiologists physical status I–III 3) Body mass index18.5~25 kg/m2 4) No obvious abnormalities in lung function, no invertebrate or thoracic malformations, no difficult airway, asthma, or COPD 5) After fully explaining the content of the clinical trial, volunteers to join and sign informed consent
Exclusion criteria
Exclusion criteria: 1) Illness with symptoms of upper respiratory tract infection or lung infection in the last 4 weeks, and chest X-rays suggest pneumonia;Severe lung diseases such as chronic obstructive pulmonary disease, pleural effusion, asthma, pneumothorax, diseases affecting lung and thoracic compliance, and a history of lung surgery such as lobectomy 2) Complicated with serious diseases, including severe liver and kidney injury, autoimmune diseases, immune deficiency, cardiovascular and cerebrovascular diseases, neuropsychiatric diseases, blood diseases, etc 3) Preoperative oxygen saturation was less than 90% 4) Poor compliance, difficult to cooperate with treatment and follow-up 5) Participated in other clinical studies in the past 3 months; 6) The researchers believe that the subjects are not suitable to participate in the study due to other reasons.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Postoperative pulmonary ultrasound score results; | — |
Secondary
| Measure | Time frame |
|---|---|
| Lung function 1 day before surgery and 1, 3 and 5 days after surgery;Arterial blood gas analysis;Pulmonary complications 1, 3, and 5 days after surgery; | — |
Countries
China
Contacts
The Second Affiliated Hospital of Anhui Medical University